Licenses and licensing conditions may vary from country to country. Please always consult your country specific SPC or package leaflet.

Privacy at Baxter

In the regular course of business, Baxter interacts and communicates directly with consumers, patients, health-care professionals, employees and others. These audiences may share their personally identifiable information with Baxter which we collect, store and process electronically and/or manually. Please see the following Global Privacy Principles that govern Baxter´s use of personally identifiable information ("Private Information"). Since Baxter has many websites developed by Baxter business units and regions that can be accessed via the www.baxter.com site, please also see the information provided in the section entitled "Baxter´s Website Policies" below.

IMPORTANT: Baxter´s Global Privacy Statement states: "In all instances, Baxter believes that it is a person´s right to have their personal information kept private. Therefore, we have an obligation to implement privacy procedures and technical security measures to keep personal information private and secure." If you should have any questions concerning Baxter´s privacy practices or wish to access or correct Private Information that Baxter has collected from you, please submit an inquiry via Baxters on-line Privacy Inquiry Form, call: 1-800-422-9837 (847-948-4770) or fax your inquiry to 847-948-3642.

Are you a Healthcare Professional?


  I am not a Healthcare Professional            I am a Healthcare Professional

Please click "Accept" to continue:
Read & scroll down to accept the Policy Statement
Select Region:
Text Size:
Glossary  |  Site Map  |  Contact Us  |  News Room
BioTherapeutics Baxter wordmark link to corporate website

Therapeutic Areas | Critical Care

Licenses and licensing conditions may vary from country to country. Please always consult your country specific SPC or package leaflet.

Product Primary Uses Product Description
FLEXBUMIN 200 g/l
and
FLEXBUMIN 250 g/l
Plasma-volume replacement therapy for the treatment of hypovolemia

Please see SPCs
A sterile, nonpyrogenic preparation of albumin in a single-dosage form for intravenous administration
HUMAN ALBUMIN 50 g/l BAXTER
and
HUMAN ALBUMIN 200 g/l BAXTER
and
HUMAN ALBUMIN 250 g/l BAXTER
Plasma-volume replacement therapy for the treatment of hypovolemia

Please see SPCs
A sterile, nonpyrogenic preparation of albumin in a single-dosage form for intravenous administration
CEPROTIN 500 IU Human Protein C
and
CEPROTIN 1000 IU Human Protein C
Severe congenital Protein C deficiency Please see SPC Powder and solvent for solution for intravenous injection
PROTHROMPLEX Total Prothrombin Complex Human Steam Treated
Treatment of bleeding and perioperative prophylaxis of bleeding in congenital and acquired deficiency of prothrombin complex coagulation factors.

Please see SPC
Powder and solvent for solution for intravenous injection
ANTITHROMBIN III Human plasma-derived Antithrombin For patients with a plasma antithrombin III (AT III) activity below 70% of normal for prophylaxis and treatment of thrombotic and thromboembolic disorders

Please see SPC
Powder and solvent for solution or injection

THERAPEUTIC AREAS

FEATURED PRODUCTS

Flexbumin

A sterile, nonpyrogenic preparation of albumin in a single-dosage

Please see SPCs

ceprotin

For the treatment of severe congenital Protein C deficiency.

Please see SPC